Cancer Immunotherapy
-
{
- All
- News
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Genomics, AI And More: Oncologist Shares Global Breakthroughs In Cancer Treatment 2025
A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened importance.
-
Research And Development In Lung Cancer
This article is a part of Lung Connect India Foundation's initiative 'Lung Cancer Awareness - United In Our Goals', focusing on lung cancer prevention, diagnosis, and treatment.
-
World Cancer Day 2021: Is Immunotherapy Changing The Future Of Lung Cancer?
In progressive lung cancer, chemotherapy gives modest advantage as most of the patients survive only a few months to a year. Chemotherapy can't be considered as a standard of care. Now, immunotherapy is changing the scenario of lung cancer treatment.
-
Weight Loss May Make Cancer Immunotherapies Ineffective
A weight loss condition that affects cancer patients may make immunotherapy ineffective, according to a new study which explains why the approach boosting a patient's immune system to treat the disease fails in a lot of people.
-
Napster Co-Founder Bankrolls Project to Speed Cancer Work
The newly created Parker Institute for Cancer Immunotherapy is being funded by a $250 million grant from Sean Parker.
-
Collaborative Institute Aims To Speed Cancer Drug Creation
A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry researchers collaborating and sharing their findings like never before.
-
Cholesterol Pill Boosts Cancer Immunotherapy, At Least In Mice
Tweaking cholesterol levels with a simple pill may boost the effectiveness of new immunotherapy drugs that are starting to revolutionise the treatment of cancers, experiments in mice suggest.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Genomics, AI And More: Oncologist Shares Global Breakthroughs In Cancer Treatment 2025
A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened importance.
-
Research And Development In Lung Cancer
This article is a part of Lung Connect India Foundation's initiative 'Lung Cancer Awareness - United In Our Goals', focusing on lung cancer prevention, diagnosis, and treatment.
-
World Cancer Day 2021: Is Immunotherapy Changing The Future Of Lung Cancer?
In progressive lung cancer, chemotherapy gives modest advantage as most of the patients survive only a few months to a year. Chemotherapy can't be considered as a standard of care. Now, immunotherapy is changing the scenario of lung cancer treatment.
-
Weight Loss May Make Cancer Immunotherapies Ineffective
A weight loss condition that affects cancer patients may make immunotherapy ineffective, according to a new study which explains why the approach boosting a patient's immune system to treat the disease fails in a lot of people.
-
Napster Co-Founder Bankrolls Project to Speed Cancer Work
The newly created Parker Institute for Cancer Immunotherapy is being funded by a $250 million grant from Sean Parker.
-
Collaborative Institute Aims To Speed Cancer Drug Creation
A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry researchers collaborating and sharing their findings like never before.
-
Cholesterol Pill Boosts Cancer Immunotherapy, At Least In Mice
Tweaking cholesterol levels with a simple pill may boost the effectiveness of new immunotherapy drugs that are starting to revolutionise the treatment of cancers, experiments in mice suggest.
